Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03885323 · ClinicalTrials.gov registry record · NA
ToothWave Plaque and Gingivitis Study
A NA study of Gingivitis and Plaque, sponsored by Home Skinovations.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
- 1
- Study location
NCT03885323: Completed NA study of Gingivitis and Plaque, sponsored by Home Skinovations.
NCT03885323 is a NA study of Gingivitis and Plaque that has completed, run by Home Skinovations. The registered enrollment target is 86 participants, below the 233-participant average among 25 other Gingivitis trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03885323, a NA study of Gingivitis and Plaque, has completed, sponsored by Home Skinovations.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to evaluate the safety and efficacy of the home-use device Silk'n toothbrush (ToothWave) for the improvement in dental health through the reduction of plaque, gingivitis, and calculus.
Primary Outcome
A reduction in the level of dental plaque according to Rustogi Modification of the Navy Plaque Index (RMNPI).
Conditions Studied
Interventions
- DEVICE RF utilizing powered toothbrush
- DEVICE Control placebo with no RF
Study Locations (1)
Indiana
- Salus research - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2019-02-28 |
| Est. Completion | 2019-04-15 |
| Phase | NA |
What the finished NCT03885323 record still lists
NCT03885323 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 233-participant average among 25 other Gingivitis trials with a reported enrollment target (63% lower).
The record links to 3 conditions, with Gingivitis appearing as the primary indexed condition, and to 2 interventions - of which RF utilizing powered toothbrush is the first listed.
NCT03885323 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03885323 about?
NCT03885323 is a clinical study titled "ToothWave Plaque and Gingivitis Study". The objective of the study is to evaluate the safety and efficacy of the home-use device Silk'n toothbrush (ToothWave) for the improvement in dental health through the reduction of plaque, gingivitis, and calculus.
What is the current status of trial NCT03885323?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2019-02-28. Estimated completion is 2019-04-15.
What conditions does trial NCT03885323 study?
This clinical trial studies the following conditions: Gingivitis, Plaque, Calculus, Dental.
What interventions are being tested in trial NCT03885323?
The interventions under investigation include: RF utilizing powered toothbrush (DEVICE), Control placebo with no RF (DEVICE).
Who is sponsoring clinical trial NCT03885323?
This trial is sponsored by Home Skinovations, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03885323 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingivitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03885323's enrollment target sits among peer trials
86 16th of 25 higher than 10 of 25 other Gingivitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gingivitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Imaging-based Assessment of Oral Biofilm and Gingival Health
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation
RECRUITING · NA
-
Effectiveness of Dual Light Electric Toothbrush vs. Manual Toothbrush in Orthodontic Patients Undergoing Oral Surgery
RECRUITING · NA
-
Variation in Gingival Inflammatory Responses
RECRUITING · NA
-
Motivational Interviewing to Improve Oral Hygiene in Adolescent Orthodontic Patients
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI